
As the U.S. grapples with an ongoing opioid crisis, a new federal government report finds that efforts to rethink physician prescribing practices and provide treatments for people who have abused opioids appear to be working.
In 2018, nearly 3 in 10 beneficiaries received at least one prescription opioid through Medicare Part D. Specifically, 29% of beneficiaries, or 13.4 million of the 46.8 million people enrolled in the program, received opioids. This was a drop from the previous year, when 31% of beneficiaries received opioids through Part D, and from 2016, when 33% received the painkillers.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.